logo-loader
viewDirecta Plus PLC

Directa Plus completes €4.1mln acquisition of a 51% stake in Romanian waste management and decontamination services business

The new operation, Setcar will be renamed Directa Environmental Solutions

Directa Plus PLC -
Directa Plus is a specialist at incorporating graphene into textiles, pollution treatments, road surfaces and tyres.

Directa Plus PLC (LON:DCTA) has completed the €4.1mln purchase of a 51% stake in Setcar, the Romanian waste management and decontamination services business.

In a brief statement, the graphene products specialist said the new operation will be renamed Directa Environmental Solutions.

"Setcar has been a business partner for a number of years and we are pleased that it is now part of the Directa Plus group,” said chief executive Giulio Cesareo.

“We are already working with the company to supply environmental services to the oil and gas industry. We look forward to growing the business using our next generation, graphene based Grafysorber adsorbant," he added.

Italy-based Directa Plus floated on AIM in 2016 and is a specialist at incorporating graphene into textiles, pollution treatments, road surfaces and tyres.

The "miracle material" is 200-times stronger than steel, transparent and can conduct heat and electricity.

Quick facts: Directa Plus PLC

Price: 75 GBX

AIM:DCTA
Market: AIM
Market Cap: £45.75 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Directa Plus PLC named herein, including the promotion by the Company of Directa Plus PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: DeepMatter to collaborate with AstraZeneca

Headlines from the Proactive UK newsroom. DeepMatter (LON:DMTR) has agreed a tie-up with AstraZeneca to combine their drug development technology platforms. Deepmatter uses AI to monitor and record chemical reactions during drug development. Rare disease database group Open Orphan...

on 9/12/19

2 min read